Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event

Summary: Genentech is the new sponsor for the "Walk to End Lupus Now" event, taking over the spot from GSK. This move shows Genentech's growing focus on helping the lupus community. Recently, their drug Gazyva was approved to treat lupus nephritis, a serious kidney issue caused by the disease. They hope Gazyva will become a top choice for doctors, competing directly with GSK's popular drug, Benlysta. The battle for the $2.5 billion lupus market is officially on!

For more details, see rssapp-fiercepharma-com at fiercepharma.com/marketing/genentech-walks-walk-lupus-sponsoring-annual-event (opens in new tab)